The Senores Pharmaceuticals' public issue will close for public bidding on Tuesday, December 24. The IPO has received 1.78x ...

Choose between Carraro India with its strong growth or Senores Pharma with high market demand. Decide your bet by!

Senores Pharmaceuticals IPO receives strong response on Day 1, with retail investors leading the way, closing on4.

Senores Pharmaceuticals Ltd. opened for day two of subscription on Monday. The Rs 582.11-crore offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs 82.11 crore. It has been ...

The initial public offering (IPO) of pharma company Senores Pharmaceuticals Ltd is set to hit Dalal Street on Friday, ...

According to stock market observers, shares of the company are available at a premium of ₹191 in the grey market today ...

The Initial Public Offering of Senores Pharmaceuticals Limited was fully subscribed on the first day of bidding.

Proceeds from the fresh issue will be used for setting up a manufacturing facility for production of sterile injections in ...

As of today and the recent trend, the grey market premium (GMP) for the Senores Pharmaceuticals IPO is Rs 150, indicating ...

Senores Pharma IPO opens today, December 20, 2024, and closes for subscription on December 24, 2024. Check issue size, price ...

Senores Pharmaceuticals Limited raised ₹261 crore from its anchor investors ahead of its public issue. The IPO is set to open ...

Senores Pharmaceuticals IPO's last GMP is Rs 150 as of 1:25 p.m. on Dec. 19, according to InvestorGain. This implies shares ...